Keywords
How to Cite
Abstract
Background:
Hemorrhoidal disease is a common benign anorectal condition. Conventional Milligan-Morgan hemorrhoidectomy remains the standard surgical treatment; however, it is often associated with considerable postoperative pain and delayed recovery. This study aims to compare the outcomes of LigaSure hemorrhoidectomy and conventional Milligan-Morgan hemorrhoidectomy in patients with third-degree hemorrhoids to determine the more effective surgical approach.
Materials and Methods:
This randomized controlled trial was conducted at the Department of General Surgery, over 6 months. 240 patients with third-degree hemorrhoids underwent either LigaSure hemorrhoidectomy or conventional Milligan-Morgan hemorrhoidectomy. Primary outcome was intraoperative blood loss, while operative time, hospital stay, and postoperative complications were assessed. Data were analyzed using SPSS version 23, with p≤0.05 considered significant.
Results:
A total of 240 patients were randomized equally into the LigaSure and conventional hemorrhoidectomy groups. LigaSure hemorrhoidectomy was associated with significantly lower intraoperative blood loss (18.6 ± 7.4 mL vs 42.3 ± 13.8 mL, p<0.001), shorter operative time (21.5 ± 4.8 vs 29.8 ± 5.7 minutes, p<0.001), and reduced hospital stay (1.2 ± 0.4 vs 1.5 ± 0.6 days, p=0.002). Postoperative bleeding (3.3% vs 9.2%, p=0.048) and anal discharge (15.0% vs 29.2%, p=0.008) were significantly less frequent in the LigaSure group, while rates of fecal incontinence and anal stenosis were comparable between the two groups.
Conclusion:
LigaSure hemorrhoidectomy was associated with improved operative outcomes and fewer postoperative complications compared with conventional Milligan-Morgan hemorrhoidectomy, making it a safe and effective option for third-degree hemorrhoids